Zinc-Doped Copper Oxide Nanocomposites Inhibit the Growth of Pancreatic Cancer by Inducing Autophagy Through AMPK/mTOR Pathway
Overview
Authors
Affiliations
Zinc doped copper oxide nanocomposites (Zn-CuO NPs) is a novel doped metal nanomaterial synthesized by our group using the sonochemical method. Our previous studies have shown that Zn-CuO NPs could inhibit cancer cell proliferation by inducing apoptosis via ROS-mediated pathway. In the present study, we studied the anticancer effect of Zn-CuO NPs on human pancreatic cancer cells. MTS assay revealed that Zn-CuO NPs was able to inhibit cancer cell growth. TEM, flow cytometry and fluorescence microscope analysis showed that Zn-CuO NPs induced autophagy significantly; the number of autophagosomes increased obviously in cells treated with Zn-CuO NPs. Western blot analysis revealed that treatment with the NPs resulted in activation of AMPK/mTOR pathway in both AsPC-1 and MIA Paca-2 cells in dose dependent manners. Moreover, in the presence of AMPK activator AMPKinone, the protein level of p-AMPK, p-ULK1, Beclin-1 and LC3-II/LC3-I increased, while the protein expression of p-AMPK, p-ULK1, Beclin-1 and LC3-II/LC3-I decreased in the presence of AMPK inhibitor Compound C. study using xenograft mice revealed that Zn-CuO NPs significantly inhibited tumor growth with low toxicity. Our study confirms that Zn-CuO NPs inhibit the tumor growth both and for pancreatic cancer. AMPK/mTOR pathway plays an important role in the NPs induced inhibition of tumor growth.
Mechanisms of Copper-Induced Autophagy and Links with Human Diseases.
Fu Y, Zeng S, Wang Z, Huang H, Zhao X, Li M Pharmaceuticals (Basel). 2025; 18(1).
PMID: 39861161 PMC: 11768742. DOI: 10.3390/ph18010099.
Trace elements in pancreatic cancer.
Yanjun Y, Jing Z, Yifei S, Gangzhao G, Chenxin Y, Qiang W Cancer Med. 2024; 13(14):e7454.
PMID: 39015024 PMC: 11252496. DOI: 10.1002/cam4.7454.
Huang Y, Gong P, Su L, Zhang M Sci Rep. 2023; 13(1):20870.
PMID: 38012210 PMC: 10682027. DOI: 10.1038/s41598-023-47223-4.
Yi J, Luo X, Xing J, Gedanken A, Lin X, Zhang C Bioeng Transl Med. 2023; 8(3):e10507.
PMID: 37206208 PMC: 10189445. DOI: 10.1002/btm2.10507.
Hesemans E, Saffarzadeh N, Maksoudian C, Izci M, Chu T, Luci C J Nanobiotechnology. 2023; 21(1):87.
PMID: 36915084 PMC: 10009859. DOI: 10.1186/s12951-023-01844-z.